Cellular Inhibitor of Apoptosis (cIAP)-mediated ubiquitination of Phosphofurin Acidic Cluster Sorting protein 2 (PACS-2) negatively regulates Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) cytotoxicity

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Guicciardi, Maria Eugenia ^a   Werneburg, Nathan W ^a   Bronk, Steven F ^a   Franke, Adrian ^a   Yagita, Hideo ^b   Thomas, Gary ^c   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PROTEASOME; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL FREE SYSTEM; CELL KILLING; CELL MEMBRANE PERMEABILITY; CELL SPECIFICITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; EMBRYO; GENE DELETION; GENE INACTIVATION; HEPATOBILIARY SYSTEM CANCER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; WILD TYPE;

APOPTOSIS; BIOMIMETIC MATERIALS; CELL LINE, TUMOR; HEPATOCYTES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR MEMBRANES; LIVER; LYSOSOMES; MITOCHONDRIAL PROTEINS; PERMEABILITY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITINATION; VESICULAR TRANSPORT PROTEINS;

EID: 84898479582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092124     Document Type: Article

References (44)

1. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401-410. (Pubitemid 34685698)
2. Srinivasula SM, Ashwell JD (2008) IAPs: what's in a name? Mol Cell 30: 123-135. (Pubitemid 351626688)
3. Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10: 561-574.
4. Eckelman BP, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988-994. (Pubitemid 44480512)
5. Eckelman BP, Salvesen GS (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281: 3254-3260. (Pubitemid 43845937)
6. Dynek JN, Vucic D (2013) Antagonists of IAP proteins as cancer therapeutics. Cancer Lett 332: 206-214.
7. Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
8. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, et al. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53.
9. Gao Z, Tian Y, Wang J, Yin Q, Wu H, et al. (2007) A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. J Biol Chem 282: 30718-30727. (Pubitemid 350035215)
10. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, et al. (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131: 669-681. (Pubitemid 350087204)
11. Vince JE, Wong WW, Khan N, Feltham R, Chau D, et al. (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131: 682-693. (Pubitemid 350103599)
12. Vogler M, Walczak H, Stadel D, Haas TL, Genze F, et al. (2009) Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res 69: 2425-2434.
13. Bockbrader KM, Tan M, Sun Y (2005) A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene 24: 7381-7388. (Pubitemid 41622242)
14. Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH (2002) Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 277: 44236-44243. (Pubitemid 36157856)
15. Guicciardi ME, Mott JL, Bronk SF, Kurita S, Fingas CD, et al. (2011) Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Exp Cell Res 317: 107-116.
16. Guicciardi ME, Bronk SF, Werneburg NW, Gores GJ (2007) cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis. Am J Physiol Gastrointest Liver Physiol 292: G1337-1346. (Pubitemid 47084667)
17. Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, Gores GJ (2007) Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem 282: 28960-28970. (Pubitemid 47606073)
18. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, et al. (2003) Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 112: 152-159. (Pubitemid 38056351)
19. Werneburg NW, Bronk SF, Guicciardi ME, Thomas L, Dikeakos JD, et al. (2012) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2). J Biol Chem 287: 24427-24437.
20. Youker RT, Shinde U, Day R, Thomas G (2009) At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem J 421: 1-15.
21. Aslan JE, You H, Williamson DM, Endig J, Youker RT, et al. (2009) Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Mol Cell 34: 497-509.
22. Atkins KM, Thomas L, Youker RT, Harriff MJ, Pissani F, et al. (2008) HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice. J Biol Chem 283: 11772-11784.
23. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863. (Pubitemid 12054507)
24. Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M (1987) Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology 7: 551-556. (Pubitemid 17073163)
25. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, et al. (1985) Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1: 579-596. (Pubitemid 15015131)
26. Feltham R, Moulin M, Vince JE, Mace PD, Wong WW, et al. (2010) Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J Biol Chem 285: 17525-17536.
27. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, et al. (2005) Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 25: 3348-3356. (Pubitemid 40464334)
28. Conte D, Holcik M, Lefebvre CA, Lacasse E, Picketts DJ, et al. (2006) Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol 26: 699-708. (Pubitemid 43090921)
29. Smith AJ, Dai H, Correia C, Takahashi R, Lee SH, et al. (2011) Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells. J Biol Chem 286: 17682-17692.
30. Guicciardi ME, Bronk SF, Werneburg NW, Yin XM, Gores GJ (2005) Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis. Gastroenterology 129: 269-284. (Pubitemid 41002060)
31. Kottgen M, Benzing T, Simmen T, Tauber R, Buchholz B, et al. (2005) Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J 24: 705-716. (Pubitemid 40396101)
32. Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, et al. (2012) Genetically defining the mechanism of Puma- and Bim-induced apoptosis. Cell Death Differ 19: 642-649.
33. Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, et al. (2004) Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med 199: 437-448. (Pubitemid 38233828)
34. Varfolomeev E, Goncharov T, Maecker H, Zobel K, Komuves LG, et al. (2012) Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Science Signal 5: ra22.
35. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252. (Pubitemid 26007814)
36. Csomos RA, Brady GF, Duckett CS (2009) Enhanced Cytoprotective Effects of the Inhibitor of Apoptosis Protein Cellular IAP1 through Stabilization with TRAF2. J Biol Chem 284: 20531-20539.
37. Mace PD, Smits C, Vaux DL, Silke J, Day CL (2010) Asymmetric recruitment of cIAPs by TRAF2. J Mol Biol 400: 8-15.
38. Gores GJ, Kaufmann SH (2001) Is TRAIL hepatotoxic? Hepatology 34: 3-6. (Pubitemid 32591476)
39. Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ (2007) Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 56: 1124-1131. (Pubitemid 47123245)
40. Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, et al. (2008) Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci USA 105: 10895-10900.
41. Gentle IE, Wong WW, Evans JM, Bankovacki A, Cook WD, et al. (2011) In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. JBiol Chem 286: 13282-13291.
42. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, et al. (2008) Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 9: 1364-1370.
43. Darding M, Feltham R, Tenev T, Bianchi K, Benetatos C, et al. (2011) Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ 18: 1376-1386.
44. Akazawa Y, Mott JL, Bronk SF, Werneburg NW, Kahraman A, et al. (2009) Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology 136: 2365-2376 e2361-2367.